Severe Malaria Observatory
Knowledge sharing for severe malaria
Search
Search
Search
English
\n
Français
\n
Search
Toggle main menu visibility
Severe malaria
What is malaria?
Global burden
Symptoms
Diagnosis
Treatment
Groups at risk
Countries
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic
Democratic Republic of Congo
Ethiopia
Ghana
Guinea
India
La Cote d'Ivoire
Madagascar
Malawi
Mali
Mozambique
Niger
Nigeria
Rwanda
Senegal
South Sudan
Tanzania
Uganda
Zambia
Drugs & markets
In the field
Severe Malaria Projects
Interviews
Toolkits & training
Injectable artesunate
Artesunate Rectal Capsules
Additional resources
Resources
News & Events
Events
Newsletter
About us
FAQ
Search
Search
Home
Resources
Severe Malaria Resources
1
Keywords
From
From
Year
-Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
To
To
Year
-Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Year
- Any -
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2008
2007
2005
1982
1981
Tags
- Any -
AQUAMAT
Acceptability
Age
ArTiMist
Asia
Asymptomatic
BCC
Burden
Burkina Faso
CHW
Cameroon
Case Management
Case definition
Central African Republic
Children
Community
Correct use
Correlation
Counterfit
DRC
Delay
Diagnosis
Disease progression
Economics
Ethiopia
Ghana
Haemolysis
ICCM
Immunity
Injectable artemether
Injectable artesunate
Injectable quinine
M&E
MATIAS
Malawi
Manifestations
Mapping
Mixed infections
Mortality
Mozambique
Nigeria
P. Knowlesi
P. Vivax
PNG
Practice
Pre-referral
Rectal artesunate
Referral
Resistance
Senegal
Severity
Stock
Substandard drugs
Sudan
Supply
Tanzania
Training
Travellers
Treatment
Treatment practices
Uganda
Vietnam
WHO
Zambia
care-seeking
Resource type
- Any -
Article
Cochrane review
Guide
Information note
Manual
Peer-reviewed article
Report
Severe malaria rapid assessment reports
Strategy
Survey results
Source
- Any -
26 Sep 2021
Transcriptome-based analysis of blood samples reveals elevation of DNA damage response, neutrophil degranulation, cancer and neurodegenerative pathways in Plasmodium falciparum patients.
22 Sep 2021
Significant differences in FcγRIIa, FcγRIIIa and FcγRIIIb genes polymorphism and anti-malarial IgG subclass pattern are associated with severe Plasmodium falciparum malaria in Saudi children.
21 Sep 2021
Computational Insights into the Interaction between Cytoadherence Receptor gC1qR and the DBLβ12 Domain of a
Plasmodium falciparum
PfEMP1 Ligand.
20 Sep 2021
The clinical-epidemiological profile of malaria patients from Southern Venezuela, a critical hotspot in Latin America.
16 Sep 2021
Prevalence of
Plasmodium
spp. in symptomatic BaAka Pygmies inhabiting the rural Dzanga Sangha region of the Central African Republic.
12 Sep 2021
Factors Associated with Prolonged Hospital Length of Stay in Adults with Imported Falciparum Malaria-An Observational Study from a Tertiary Care University Hospital in Berlin, Germany.
09 Sep 2021
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal
Salmonella
bacteremia.
09 Sep 2021
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
08 Sep 2021
Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
07 Sep 2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
06 Sep 2021
Combining malaria vaccination with chemoprevention: a promising new approach to malaria control.
03 Sep 2021
Evolutionary trilogy of malaria, angiotensin II and hypertension: deeper insights and the way forward.
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »
0
Malaria ministerial conference documents
06 Mar 2024
Malaria Ministerial Conference documents
30 Nov 2023
WHO Malaria Policy Advisory Group (MPAG) meeting report
06 Mar 2024
Yaoundé declaration